These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 12017227)
1. Autoantibodies in children with type 2 diabetes mellitus. Umpaichitra V; Banerji MA; Castells S J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():525-30. PubMed ID: 12017227 [TBL] [Abstract][Full Text] [Related]
2. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients]. Reinsch B; Zimmy S; Schatz H; Pfohl M Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530 [TBL] [Abstract][Full Text] [Related]
3. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus. Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623 [TBL] [Abstract][Full Text] [Related]
4. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus. Arikan E; Sabuncu T; Ozer EM; Hatemi H J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499 [TBL] [Abstract][Full Text] [Related]
5. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus. Gupta M; Graham J; McNeeny B; Zarghami M; Landin-Olsson M; Hagopian WA; Palmer J; Lernmark A; Sanjeevi CB Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560 [TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea. Kim CS; Nam JH; Nam JS; Park JS; Kang ES; Ahn CW; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB Metabolism; 2006 Aug; 55(8):1107-12. PubMed ID: 16839848 [TBL] [Abstract][Full Text] [Related]
7. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases. Lindholm E; Hallengren B; Agardh CD Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992 [TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of humoral and metabolic markers as an evaluation of risk for developing type 1 diabetes]. Młynarski W; Wyka K; Bodalska-ŁIpińska J; Andrzejewski W; Zmysłowska A; Bodalski J Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):17-22. PubMed ID: 12831633 [TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients. Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapy. Fukui M; Nakano K; Shigeta H; Yoshimori K; Fujii M; Kitagawa Y; Mori H; Kajiyama S; Nakamura N; Abe N; Obayashi H; Fukui I; Ohta K; Ohta M; Kondo M Diabet Med; 1997 Feb; 14(2):148-52. PubMed ID: 9047093 [TBL] [Abstract][Full Text] [Related]
11. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2. Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100 [TBL] [Abstract][Full Text] [Related]
13. [Use of ABC typing to redefine subtypes of acute-onset type 1 diabetes mellitus: study of 308 patients]. Zhang C; Zhou ZG; Lin J; Huang G; Wang JP; Zhang DM; Zhou M; Yang XL Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):797-801. PubMed ID: 18756979 [TBL] [Abstract][Full Text] [Related]
14. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies. Franke B; Galloway TS; Wilkin TJ Diabetes Metab Res Rev; 2005; 21(5):395-415. PubMed ID: 15895384 [TBL] [Abstract][Full Text] [Related]
15. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus]. Perusicová J; Bárová H; Hill M; Masek Z Vnitr Lek; 2002 Jun; 48(6):490-9. PubMed ID: 12132349 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital. Römkens TE; Kusters GC; Netea MG; Netten PM Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158 [TBL] [Abstract][Full Text] [Related]
17. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis. Katz LE; Jawad AF; Ganesh J; Abraham M; Murphy K; Lipman TH Pediatr Diabetes; 2007 Apr; 8(2):53-9. PubMed ID: 17448127 [TBL] [Abstract][Full Text] [Related]
18. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus]. Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312 [TBL] [Abstract][Full Text] [Related]
19. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease. Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318 [TBL] [Abstract][Full Text] [Related]
20. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years. Betterle C; Lazzarotto F; Fusari A; Zanchetta R; Benedini S; Pedini B; Moscon A; Presotto F Acta Diabetol; 2006 Nov; 43(3):79-83. PubMed ID: 17143785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]